• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压老年患者血压下降与 Tau 病理学和记忆衰退相关。

Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.

机构信息

Department of Psychiatry, Center for Brain Health, New York University School of Medicine, New York, NY, USA; Department of Radiology, New York University School of Medicine, New York, NY, USA.

出版信息

Neurobiol Aging. 2014 Jan;35(1):64-71. doi: 10.1016/j.neurobiolaging.2013.06.011. Epub 2013 Aug 19.

DOI:10.1016/j.neurobiolaging.2013.06.011
PMID:23969178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3799812/
Abstract

In hypertension (HTN), cerebral blood flow regulation limits are changed, and the threshold for blood pressure (BP) at which perfusion is safely maintained is higher. This shift may increase the brain's vulnerability to lower BP in subjects with vascular disease. We investigated whether longitudinal reduction in mean arterial pressure (MAP) was related to changes in cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease in a group of cognitively healthy elderly with and without HTN. The relationships among MAP, memory decline, and hippocampal atrophy were also examined. Seventy-seven subjects (age 63.4 ± 9.4, range 44-86 years; education 16.9 ± 2.1, range 10-22 years; 60% women) were assessed twice, 2 ± 0.5 years apart. At both time points, all subjects underwent full medical and neuropsychological evaluations, lumbar punctures, and magnetic resonance imaging examinations. Twenty-five subjects had HTN. Hyper- and normotensive subjects did not differ in their CSF biomarkers, hippocampal volumes (HipVs), or memory scores at baseline. In the entire study group, the increase in tau phosphorylated at threonine 181 (p-tau(181)) was associated with a decline in verbal episodic memory (β = -0.30, p = 0.01) and HipV reduction (β = -0.27, p = 0.02). However, longitudinal decrease in MAP was related to memory decline (β = 0.50, p = 0.01) and an increase in p-tau(181) (β = -0.50, p = 0.01) only in subjects with HTN. Our findings suggest that the hypertensive group may be sensitive to BP reductions.

摘要

在高血压(HTN)中,脑血流调节极限发生改变,血压维持灌注的安全阈值升高。这种转变可能会增加血管疾病患者的大脑对较低血压的脆弱性。我们研究了在一组认知健康的老年人群中,有无高血压,平均动脉压(MAP)的纵向降低是否与阿尔茨海默病的脑脊液(CSF)生物标志物变化有关。还检查了 MAP、记忆下降和海马萎缩之间的关系。77 名受试者(年龄 63.4±9.4 岁,范围 44-86 岁;教育程度 16.9±2.1 年,范围 10-22 年;60%为女性)在 2±0.5 年的时间间隔内接受了两次评估。在两次时间点,所有受试者都接受了全面的医学和神经心理学评估、腰椎穿刺和磁共振成像检查。25 名受试者患有高血压。在基线时,高血压和正常血压受试者的 CSF 生物标志物、海马体积(HipV)或记忆评分无差异。在整个研究组中,tau 第 181 位苏氨酸磷酸化(p-tau(181))的增加与言语情景记忆(β=-0.30,p=0.01)和 HipV 减少(β=-0.27,p=0.02)呈负相关。然而,MAP 的纵向下降仅与高血压患者的记忆下降(β=0.50,p=0.01)和 p-tau(181)的增加(β=-0.50,p=0.01)有关。我们的发现表明,高血压组可能对血压降低敏感。

相似文献

1
Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.高血压老年患者血压下降与 Tau 病理学和记忆衰退相关。
Neurobiol Aging. 2014 Jan;35(1):64-71. doi: 10.1016/j.neurobiolaging.2013.06.011. Epub 2013 Aug 19.
2
Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects.认知健康受试者中阿尔茨海默病 CSF 生物标志物和血压的纵向变化轨迹。
Alzheimers Dement. 2024 Jul;20(7):4389-4400. doi: 10.1002/alz.13800. Epub 2024 May 29.
3
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.基线脑脊液磷酸化tau蛋白水平可独立预测阿尔茨海默病中海马萎缩的进展。
Neurology. 2009 Sep 22;73(12):935-40. doi: 10.1212/WNL.0b013e3181b879ac.
4
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.磷酸化 tau 231、记忆减退和正常老年人的内侧颞叶萎缩。
Neurobiol Aging. 2011 Dec;32(12):2131-41. doi: 10.1016/j.neurobiolaging.2009.12.026. Epub 2010 Feb 4.
5
Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects.老年 APOE2 正常受试者的海马萎缩率和脑脊液生物标志物。
Neurology. 2010 Nov 30;75(22):1976-81. doi: 10.1212/WNL.0b013e3181ffe4d1. Epub 2010 Oct 27.
6
Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.tau 蛋白与阿尔茨海默病脑脊液生物标志物水平正常的认知健康受试者的纵向记忆下降有关。
J Alzheimers Dis. 2019;70(1):211-225. doi: 10.3233/JAD-190046.
7
Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.认知正常的老年人中阿尔茨海默病脑脊液生物标志物与认知的关系。
Neuropsychologia. 2015 Nov;78:63-72. doi: 10.1016/j.neuropsychologia.2015.09.024. Epub 2015 Sep 21.
8
Anti-Hypertensive Drugs Moderate the Relationship of Blood Pressure with Alzheimer's Pathologies and Neurodegenerative Markers in Non-Demented Hypertensive Older Adults.抗高血压药物调节非痴呆高血压老年患者血压与阿尔茨海默病病理和神经退行性标志物的关系。
J Prev Alzheimers Dis. 2024;11(3):672-683. doi: 10.14283/jpad.2024.40.
9
The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.血管内皮生长因子在神经退行性变和认知衰退中的作用:探索与阿尔茨海默病生物标志物的相互作用
JAMA Neurol. 2015 May;72(5):520-9. doi: 10.1001/jamaneurol.2014.4761.
10
The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology.海马体长轴-与潜在的 tau 和 TDP-43 病理学的关系。
Neurobiol Aging. 2018 Oct;70:1-9. doi: 10.1016/j.neurobiolaging.2018.05.035. Epub 2018 Jun 1.

引用本文的文献

1
Is late-life vulnerability to cardiovascular disease risk associated with longitudinal tau accumulation in older adults with mild cognitive impairment?晚年对心血管疾病风险的易感性是否与轻度认知障碍老年人的纵向tau蛋白积累有关?
JAR Life. 2025 Feb 18;14:100001. doi: 10.1016/j.jarlif.2025.100001. eCollection 2025.
2
Alterations in the inflammatory homeostasis of aging-related cardiac dysfunction and Alzheimer's diseases.衰老相关心脏功能障碍和阿尔茨海默病炎症稳态的改变。
FASEB J. 2025 Jan 15;39(1):e70303. doi: 10.1096/fj.202402725RR.
3
Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects.认知健康受试者中阿尔茨海默病 CSF 生物标志物和血压的纵向变化轨迹。
Alzheimers Dement. 2024 Jul;20(7):4389-4400. doi: 10.1002/alz.13800. Epub 2024 May 29.
4
Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study.探讨伴或不伴糖尿病的高血压对阿尔茨海默病风险的影响:一项临床病理研究。
Alzheimers Dement. 2024 Apr;20(4):2766-2778. doi: 10.1002/alz.13717. Epub 2024 Feb 29.
5
Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.SPRINT 试验中的血压变异性与血浆阿尔茨海默病生物标志物。
J Alzheimers Dis. 2024;97(4):1851-1860. doi: 10.3233/JAD-230930.
6
Uncoupling of Ca sparks from BK channels in cerebral arteries underlies hypoperfusion in hypertension-induced vascular dementia.高血压诱导血管性痴呆中脑动脉的钙火花与 BK 通道解偶联导致低灌注。
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2307513120. doi: 10.1073/pnas.2307513120. Epub 2023 Aug 7.
7
Hypertension, antihypertensive drugs, and age at onset of Huntington's disease.高血压、抗高血压药物与亨廷顿病发病年龄。
Orphanet J Rare Dis. 2023 May 24;18(1):125. doi: 10.1186/s13023-023-02734-1.
8
Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein ɛ4 Carriers versus Apolipoprotein ɛ3 Homozygotes.载脂蛋白 E4 携带者与载脂蛋白 E3 纯合子个体的访间血压变异性与认知衰退。
J Alzheimers Dis. 2023;93(2):533-543. doi: 10.3233/JAD-221103.
9
Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology.社论:睡眠、昼夜节律紊乱及其他可改变的风险因素对阿尔茨海默病病理的既定和新型血浆生物标志物的累加或协同影响。
Front Aging Neurosci. 2023 Mar 14;15:1168062. doi: 10.3389/fnagi.2023.1168062. eCollection 2023.
10
The impact of a high-sodium diet regimen on cerebrovascular morphology and cerebral perfusion in Alzheimer's disease.高钠饮食方案对阿尔茨海默病脑血管形态和脑灌注的影响。
Cereb Circ Cogn Behav. 2023 Jan 29;4:100161. doi: 10.1016/j.cccb.2023.100161. eCollection 2023.

本文引用的文献

1
Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study.低血压和降压治疗与动脉疾病患者的身心健康状况独立相关:SMART 研究。
J Intern Med. 2013 Sep;274(3):241-51. doi: 10.1111/joim.12069. Epub 2013 Apr 11.
2
Pulse pressure, arterial stiffness, and end-organ damage.脉搏压、动脉僵硬度与靶器官损害。
Curr Hypertens Rep. 2012 Aug;14(4):339-44. doi: 10.1007/s11906-012-0272-9.
3
Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study.高血压与脑血流的纵向变化:SMART-MR 研究。
Ann Neurol. 2012 Jun;71(6):825-33. doi: 10.1002/ana.23554. Epub 2012 Mar 23.
4
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans.心脏骤停导致的缺氧会引起人类血清淀粉样蛋白 β 水平的时间依赖性增加。
PLoS One. 2011;6(12):e28263. doi: 10.1371/journal.pone.0028263. Epub 2011 Dec 14.
5
Alzheimer disease biomarkers are associated with body mass index.阿尔茨海默病生物标志物与体重指数有关。
Neurology. 2011 Nov 22;77(21):1913-20. doi: 10.1212/WNL.0b013e318238eec1.
6
Evidence for ordering of Alzheimer disease biomarkers.阿尔茨海默病生物标志物排序的证据。
Arch Neurol. 2011 Dec;68(12):1526-35. doi: 10.1001/archneurol.2011.183. Epub 2011 Aug 8.
7
Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease.脑缺血加重阿尔茨海默病大鼠模型的认知障碍。
Life Sci. 2011 Jul 18;89(3-4):86-92. doi: 10.1016/j.lfs.2011.04.024. Epub 2011 May 18.
8
Cerebrovascular regulation during transient hypotension and hypertension in humans.人类在短暂低血压和高血压期间的脑血管调节。
Hypertension. 2010 Aug;56(2):268-73. doi: 10.1161/HYPERTENSIONAHA.110.152066. Epub 2010 Jun 14.
9
Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.低血容量性灌注不足对 tau 和淀粉样-β 的影响不同。
Am J Pathol. 2010 Jul;177(1):300-10. doi: 10.2353/ajpath.2010.090750. Epub 2010 May 14.
10
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.老年队列中的长期血压波动与脑血管疾病
Arch Neurol. 2010 May;67(5):564-9. doi: 10.1001/archneurol.2010.70.